Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Josef, Karban"'
Publikováno v:
European Journal of Histochemistry, Vol 68, Iss 3 (2024)
The present study was undertaken to provide more information on the peripheral RNA containing ring of ringshaped nucleoli (RSNo). Human lymphocytes of blood donors and patients suffering from B chronic lymphocytic leukemia mostly characterized by RSN
Externí odkaz:
https://doaj.org/article/f249dff696a74e2d89a5565c9353e4af
Autor:
Jan Molinský, Anna Panovská, Stanislava Hrobková, Heidi Mocikova, Marek Trněný, Josef Karban, Petra Obrtlikova, Michael Doubek, Lekaa Mohammadova, Martin Simkovic, Jan Novák, Martin Spacek, Lukas Smolej, Eduard Cmunt
Publikováno v:
Leukemia Research. 79:17-21
Chemoimmunotherapy with bendamustine and rituximab is an alternative treatment for elderly patients with CLL. The aim of this observational multicenter study was to prospectively assess efficacy and safety of bendamustine and rituximab in front-line
Autor:
Petra, Vockova, Jan, Molinsky, Magdalena, Klanova, Josef, Karban, Martin, Spacek, Ondrej, Havranek, Kristyna, Kupcova, Dmitry, Kazantsev, Marek, Trneny, Pavel, Klener
Publikováno v:
Leukemialymphoma. 62(4)
Platelet/endothelial cell adhesion molecule 1 (PECAM-1, CD31) is an immunoglobulin superfamily member expressed on the surface of platelets, leukocytes and endothelial cells. The role of CD31 in biology of lymphomas has not yet been systemically stud
Autor:
Yvona Brychtová, Martin Trbušek, Lukas Smolej, Jitka Malčíková, Anna Panovská, Jana Chovancová, Jana Šmardová, Petra Obrtlikova, Ludmila Šebejová, Eva Jelinkova, Michael Doubek, Jakub Trizuljak, Markéta Hadrabová, Pavlína Volfová, Jiri Mayer, Denisa Bakesova, Šárka Pospíšilová, Josef Karban, Alexandra Oltová, Karla Plevová, Marek Mráz, Olga Stehlíková
Publikováno v:
American Journal of Hematology. 90:417-421
The treatment of relapsed/refractory chronic lymphocytic leukemia (CLL) remains a challenging clinical issue. An important treatment option is the use of high-dose corticosteroids. The purpose of this clinical trial was to determine the efficacy and
Publikováno v:
European Journal of Haematology. Dec2010, Vol. 85 Issue 6, p496-501. 6p. 2 Charts, 3 Graphs.
Autor:
Petra Basova, Vojtech Kulvait, Šárka Pospíšilová, Josef Karban, Nikola Curik, Vit Pospisil, Emanuel Necas, Marek Mráz, Jiri Zavadil, Petra Obrtlikova, Tomas Stopka, Marek Trneny, Jiri Mayer, Karin Vargova, Filipp Savvulidi, Pavel Burda, Adela Berkova, Juraj Kokavec
Publikováno v:
Blood. 117:3816-3825
Elevated levels of microRNA miR-155 represent a candidate pathogenic factor in chronic B-lymphocytic leukemia (B-CLL). In this study, we present evidence that MYB (v-myb myeloblastosis viral oncogene homolog) is overexpressed in a subset of B-CLL pat
Autor:
Marek Trněný, Robert Pytlik, K Benesova, H Rychtrmocová, Veselá R, Josef Karban, Henning Morawietz, Winfried Goettsch, Kideryová L
Publikováno v:
Hematological Oncology. 28:192-201
Our objective was to study the kinetics of circulating endothelial cells (EC) and endothelial precursor cells (EPC) in hematological patients during chemotherapy and autologous stem cell transplantion (ASCT). Eighteen newly diagnosed patients and 17
Autor:
Adela Berkova, Josef Karban, Eduard Cmunt, Lenka Pavlistova, Schwarz J, Zuzana Zemanova, Marek Trneny, Kyra Michalova, Jana Brezinova
Publikováno v:
Neoplasma. 56:455-458
The results of repeated interphase fluorescence in-situ hybridization (I-FISH, FISH) examination of 97 CLL patients and correlation of these findings with IgVH hypermutation status, ZAP-70 and CD38 expression are presented. The appearance of new, FIS
Autor:
Marek Trneny, Josef Karban, Nina Dusilkova, Hana Huskova, Tomas Stopka, Katarina Korecka, Jarmila Vargova, Karina Vargova
Publikováno v:
International journal of hematology. 102(4)
The transcription factor PU.1 and its inhibitory microRNA-155 (miR-155) are important regulators of B-cell differentiation. PU.1 downregulation coupled with oncogenic miR-155 upregulation has been reported in lymphoid malignancies; however, these dat
Autor:
Jana Březinová, Soňa Peková, Zuzana Zemanova, Kyra Michalova, Sarka Ransdorfova, Lenka Šindelářová, Eduard Cmunt, Jiří Schwarz, Josef Karban
Publikováno v:
Cancer Genetics and Cytogenetics. 160:27-34
B-chronic lymphocytic leukemia (B-CLL) is the most common adult leukemia. Molecular genetic characterization of B-CLL has made significant progress and typical chromosomal anomalies have been assessed. The most frequent chromosomal abnormalities are